The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious...
Background
The programmatic management of latent tuberculosis infection (LTBI) in populations most at risk of developing TB remains a critical activity to disrupt Mycobacterium tuberculosis transmission, as identified in the End TB Strategy. LTBI is defined as a state of persistent immune response to sti...
Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or ...
This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance. This guideline includes recommendations on: treatment; reassessment; referral and seeking specialist ...
This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance. This guideline includes recommendations on: managing acute prostatitis, including treatment, reassessment and referral; choice of antibiotic; and self...
This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance. This guideline includes recommendations on: managing...
This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease. This guideline includes recommendations on: being aware of ...
Nishida, Osamu;
Ogura, Hiroshi;
Egi, Moritoki;
Fujishima, Seitaro;
Hayashi, Yoshiro;
Iba, Toshiaki;
Imaizumi, Hitoshi;
Inoue, Shigeaki;
Kakihana, Yasuyuki;
Kotani, Joji;
Kushimoto, Shigeki;
Masuda, Yoshiki;
Matsuda, Naoyuki;
Matsushima, Asako;
Nakada, Taka-aki;
Nakagawa, Satoshi;
Nunomiya, Shin;
Sadahiro, Tomohito;
Shime, Nobuaki;
Yatabe, Tomoaki;
Hara, Yoshitaka;
Hayashida, Kei;
Kondo, Yutaka;
Sumi, Yuka;
Yasuda, Hideto;
Aoyama, Kazuyoshi;
Azuhata, Takeo;
Doi, Kent;
Doi, Matsuyuki;
Fujimura, Naoyuki;
Fuke, Ryota;
Fukuda, Tatsuma;
Goto, Koji;
Hasegawa, Ryuichi;
Hashimoto, Satoru;
Hatakeyama, Junji;
Hayakawa, Mineji;
Hifumi, Toru;
Higashibeppu, Naoki;
Hirai, Katsuki;
Hirose, Tomoya;
Ide, Kentaro;
Kaizuka, Yasuo;
Kan’o, Tomomichi;
Kawasaki, Tatsuya;
Kuroda, Hiromitsu;
Matsuda, Akihisa;
Matsumoto, Shotaro;
Nagae, Masaharu;
Onodera, Mutsuo;
Ohnuma, Tetsu;
Oshima, Kiyohiro;
Saito, Nobuyuki;
Sakamoto, So;
Sakuraya, Masaaki;
Sasano, Mikio;
Sato, Norio;
Sawamura, Atsushi;
Shimizu, Kentaro;
Shirai, Kunihiro;
Takei, Tetsuhiro;
Takeuchi, Muneyuki;
Takimoto, Kohei;
Taniguchi, Takumi;
Tatsumi, Hiroomi;
Tsuruta, Ryosuke;
Yama, Naoya;
Yamakawa, Kazuma;
Yamashita, Chizuru;
Yamashita, Kazuto;
Yoshida, Takeshi;
Tanaka, Hiroshi;
Oda, Shigeto.
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (JSSCG 2016), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese
Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, wa...
